NSECertificate under SEBI (Depositories and Participants) Regulations, 20187 Oct 2026 · 7 Oct 2026, 01:11 pm

Certificate under SEBI (Depositories and Participants) Regulations, 2018

Mangalam Drugs And Organics Limited · MANGALAM

✦ AI SummaryRegulatory

Mangalam Drugs And Organics Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk8/10
Balance Sheet Risk3/10
Liquidity Impact6/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Mangalam Drugs And Organics Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018

Attachments (1)

📄

MANGALAM_07102026131053_SE35.pdf

pdf

Download →
View document text
Mangalam Drugs and Organics Limited Regd: fice R @u 9p 1a -m 2 B 2u -i 6ld 2i 6n 1g, 6 23 0rd 0 /F 6lo 3o 0r, 0 /2 83 79 8p 7. D ®‘ M 9o 1] -; 2R 2o -a 6d 26, 9Ne 0a 9r G o. CP. N0. LM 2u 4m 2b 3a 0i 140 90 2( P5 LC 116413 REF: MDOL/CS-SE/2026-27/035 October 07,2026 Listing Department BSE Ltd Listing Department 1t Floor, New Trade Wing, National Stock Exchange of India Phiroze Jeejeebhoy Towers, Limited Dalal Street, Fort, “Exchange Plaza”, 5t Floor, Mumbai - 400 001 Plot No. C-1, Block G, Bandra - Kurla Complex, Bandra(E), Mumbai - 400 051 Scrip Code: 532637 Symbol: MANGALAM Subject: eIm n nd di e d Sm eptemi btm o er ri 30, 2m 026 im ci m lm ati n 2 u Ir m aj Dear Sir/Madam, 2h LaI e 0in n mr 2dt ie 6 e twP r ea tim d or ts ” t h S i Ro ecf eti p gp hR tia ee esn g mttu Cs r bl o) a ea m r rt R p aei l 3ngo 0iun d ,al n7 a S 2c4 t h 0( i e a 2o5 6rn) .eCs eo , Trf rt 2 i at 0 fh n1 ie sc8 faS , ete reac su A r a gai s et m ni e re tens c o da e fen i td vd he efE d r x Coc ofmh r m a o ptn mi ag m ne e “ y MB t fo Uo o a F rtr Gi td m h e eo I f n pp tI l ein e rd ma ii es oa e d I( f fnD i rde n i op d a m o a s t Ji P utt r la io yc vr h a 0i e t 1e ,eds We request your good office to kindly take the above certificate on record, Thanking You, Yours Faithfully, For Mangalam Drugs & Organics Limited Govardhan M. Dhoot Managing Director DIN:01240086 Factory : at Vapi (Gujarat) India ® contactus@mangalamdrugs.com @ http://www.m. angalamdrugs.com MUFG Intime India Private Limited M U FG (Formerly Link Intime India Private Limited) CIN: U67190MH1999PTC118368 Registered Address: C-101, Embassy 247, L.B.S. Marg, Vikhroli (West), Mumbai - 400083. Tel: +91 224918 6000 www.in.mpms.mufg.com To, Date: 03-10-2026 The Compliance Officer/ Company Secretary MANGALAM DRUGS & ORGANICS LIMITED 3RD FLOOR, RUPAM BUILDING 239, P.D. MELLO ROAD MUMBAI MUMBAI PINCODE : 400001 Sub: Confirmation Certificate under Regulation 74(5) of Securies and Exchange Board of India (Depositories and Participants) Regulations, 2018. Dear Sir/Madam, In reference to the above captioned regulation, we hereby confirm that the securities received from the depository participants for dematerialisation during the quarter ended 30th September 2026, were confirmed (acceptedirejected) to the depositories by us and that securities comprised in the said certificates have been listed on the stock exchanges where the earlier issued securities are listed. We hereby also confirm that the security certificates received for dematerialisation have been confirmedirejected and the security certificates received were mutilated and cancelled after due verification by the depository participant and the name of the depositories have been substituted in the register of members as the registered owner within the prescribed timelines. We request you to kindly take note of the above in your records. Thanking you, Yours faithfully, For MUFG Intime India Private Limited (Formerly Link Intime India Private Limited) Ashok Shetty Sr. Vice President-Corporate Registry MUFG Intime India Private Limited Apartof MUFG Corporate Markets, a division of MUFG Pension & Market Services